Immune-inflamed cancers can be responsive to immunotherapies; however, their granular characterization is challenging. iBRIDGE integrates and ‘bridges’ bulk and scRNA-seq datasets and can be used to identify cell-type specific markers… Click to show full abstract
Immune-inflamed cancers can be responsive to immunotherapies; however, their granular characterization is challenging. iBRIDGE integrates and ‘bridges’ bulk and scRNA-seq datasets and can be used to identify cell-type specific markers of immune-inflamed tumors in multiple tumor cohorts.
Keywords:
cell;
type specific;
specific markers;
inflamed tumors;
markers immune;
cell type
Journal Title: Cancer Immunology Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer Immunology Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!